A detailed history of Washington Trust Advisors, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 856 shares of VTRS stock, worth $10,717. This represents 0.0% of its overall portfolio holdings.

Number of Shares
856
Previous 856 -0.0%
Holding current value
$10,717
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

SELL
$8.77 - $10.85 $1,631 - $2,018
-186 Reduced 17.85%
856 $9,000
Q2 2023

Jul 27, 2023

SELL
$9.02 - $10.29 $1,668 - $1,903
-185 Reduced 15.08%
1,042 $10,000
Q2 2022

Jul 25, 2022

SELL
$9.95 - $12.27 $1,512 - $1,865
-152 Reduced 11.02%
1,227 $13,000
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $16,672 - $20,243
1,379 New
1,379 $19,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.